Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
58.400,81
-3,61%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ 10x Genomics Inc (TXG) 10x Genomics Inc (TXG) Notizie

10x Genomics Inc

TXG
26,90
-2,38 (-8,13%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 00:17:32
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202422:05PRNUS10x Genomics Reports First Quarter 2024 Financial Results
10/4/202422:05PRNUS10x Genomics to Report First Quarter 2024 Financial Results..
26/3/202414:00PRNUS10x Genomics Commercially Launches Visium HD Spatial Gene..
21/3/202421:05PRNUS10x Genomics Expands Xenium Menu with Multi-Modal Cell..
13/3/202421:05PRNUS10x Genomics Begins Commercial Shipments of Chromium GEM-X..
06/3/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:40EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202401:19EDGAR2Form 144 - Report of proposed sale of securities
23/2/202401:06EDGAR2Form 144 - Report of proposed sale of securities
23/2/202400:59EDGAR2Form 144 - Report of proposed sale of securities
20/2/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:05PRNUS10x Genomics to Present at the 44th Annual TD Cowen Health..
15/2/202423:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/2/202423:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202422:05EDGAR2Form 8-K - Current report
15/2/202422:05PRNUS10x Genomics Reports Fourth Quarter and Full Year 2023..
13/2/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202422:05PRNUS10x Genomics Expands Leadership in Single Cell Analysis with..
05/2/202422:05PRNUS10x Genomics to Showcase New Cutting-Edge Technologies and..
24/1/202422:05PRNUS10x Genomics to Report Fourth Quarter and Full Year 2023..
18/1/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202400:08EDGAR2Form 144 - Report of proposed sale of securities
16/1/202422:07EDGAR2Form 8-K - Current report
08/1/202415:00EDGAR2Form 8-K - Current report
08/1/202415:00PRNUS10x Genomics Announces Preliminary Fourth Quarter and Full..
29/12/202322:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:05PRNUS10x Genomics to Present at the 42nd Annual J.P. Morgan..
20/12/202322:05PRNUS10x Genomics Launches Xenium Catalyst Network
19/12/202315:00PRNUSIntegrative Study Conducted by 10x Genomics Combines Single..
18/12/202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202323:09EDGAR2Form 144 - Report of proposed sale of securities
13/12/202322:26PRNUSHigh Sensitivity and Specificity of the Xenium Platform from..
07/12/202315:00PRNUS10x Genomics and NIH CARD to Create Comprehensive Single..
28/11/202300:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202300:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202300:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202300:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:25EDGAR2Form 144 - Report of proposed sale of securities
22/11/202322:25EDGAR2Form 144 - Report of proposed sale of securities
22/11/202322:08EDGAR2Form 144 - Report of proposed sale of securities
21/11/202300:08EDGAR2Form 144 - Report of proposed sale of securities
17/11/202323:22PRNUS10x Genomics Wins Another Patent Infringement Case Against..
16/11/202322:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202322:05PRNUSOWKIN Integrates 10x Genomics Spatial Omics and Single-Cell..
02/11/202321:05EDGAR2Form 8-K - Current report
Apertura: 26,50 Min: 24,60 Max: 27,49
Chiusura: 29,28

La tua Cronologia

NASDAQ
TXG
10x Genomics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network